Navigation Links
Regional Biotech Association Urges Support for Biosimilars Bill in Congress
Date:9/22/2009

BOSTON, Sept. 22 /PRNewswire/ -- A vast coalition of New England business leaders today joined the New England Biotech Association (NEBA) to push for Congress to approve a legislative pathway for biosimilars that protect patient safety but also provide sufficient incentives for new innovative products to be developed.

NEBA and 27 other organizations and biotechnology leaders across New England said in a letter to all members of the New England congressional delegation that the biosimilars legislation is the single biggest issue in protecting the future viability and growth of New England's biotechnology industry: "New biologic medicines represent the greatest hope for treating diseases such as cancer, asthma, Parkinson's, and Alzheimers. It is crucial that biosimilars legislation preserve the incentives necessary for biotech researchers to develop the next breakthrough medical treatments. These incentives should include an appropriate period of 12-years of data exclusivity to allow New England's biotech companies to attract and protect the massive investment necessary to develop a biologic."

During its recent consideration of health care reform legislation, both the Senate Health, Education, Labor and Pensions (HELP) Committee and the House Energy and Commerce Committee adopted bipartisan amendments that provide a safe, effective and reasonable pathway for the approval of biosimilars. These amendments, approved by overwhelmingly bipartisan votes, strike the right balance between expanding competition to lower costs for consumers and preserving incentives for continued biomedical innovation by providing a 12-year period of data exclusivity.

If the final legislation approved by Congress does not protect patient safety and provide sufficient incentives for investment in innovative new biologic medicines, it would deliver a devastating blow to the hope held by millions of patients and seriously undermine the region's biotech sector."

As the regional policy and public affairs voice for the biotechnology and biopharmaceutical community, NEBA represents state biotech associations, companies, academic institutions, and other organizations from all six New England states.

To find out more about NEBA, visit www.newenglandbiotech.org


'/>"/>
SOURCE New England Biotech Association
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Center for Molecular Medicine Only Regional Provider of Test Suggested in FDA Alert on Prescribing Codeine to Nursing Mothers
2. A Magnetic Gift: Sumter Regional Hospital Receives New MRI as Charitable Donation From Siemens
3. onTargetjobs Announces Acquisition of RegionalHelpWanted.com
4. JobLoft.com Strengthens Local Market Candidate Reach Through RegionalHelpWanted.com Acquisition
5. BioSpace.com Strengthens Local Market Candidate Reach Through RegionalHelpWanted.com Acquisition
6. Hcareers.com Strengthens Local Market Candidate Reach Through RegionalHelpWanted.com Acquisition
7. China Biopharma Reaches Agreement with a Regional Pharma to Launch New Pharmaceutical Products
8. New Regional Biotech Association Formed
9. Shasta Regional Medical Center Awarded Full Accreditation from the Joint Commission
10. Regional Biotech Association Warns Vermont Legislation Could Have Profound Negative Impact
11. Midwest Research Institute Expands in Kansas to Support Regional Economic Development in Animal Health, Biosecurity, and Bioenergy Sectors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... May 27, 2016 , ... Doctors in Italy, Japan, the UK and the ... associated protein (BAP1) gene and its link to malignant mesothelioma. Surviving Mesothelioma has just ... the full article now. , The studies analyzed for the new report included ...
(Date:5/27/2016)... , May 27, 2016 At present, ... playing in this space know that volatility is what makes ... companies on ActiveWallSt.com: Synta Pharmaceuticals Corp. (NASDAQ: SNTA ... Inc. (NASDAQ: LPTN ), and Heat Biologics Inc. ... access to the technical alerts for these stocks at: ...
(Date:5/26/2016)... Jersey and READING, England ... Indegene ( http://www.indegene.com ), a leading global ... life science, pharmaceutical and healthcare organisations and TranScrip ... innovative scientific support throughout the product lifecycle, today ... the launch of IntraScience.      (Logo: ...
(Date:5/26/2016)... , May 26, 2016 Despite the ... value in this space. Today,s pre-market research on ActiveWallSt.com directs ... Health Inc. (NASDAQ: RDUS ), Cerus Corp. (NASDAQ: ... ARWR ), and Five Prime Therapeutics Inc. (NASDAQ: ... briefings at: http://www.activewallst.com/ On ...
Breaking Biology Technology:
(Date:5/9/2016)... , UAE, May 9, 2016 ... when it comes to expanding freedom for high net ... Even in today,s globally connected world, there is ... conferencing system could ever duplicate sealing your deal with ... obtaining second passports by taking advantage of citizenship via ...
(Date:4/26/2016)... BANGALORE, India and LONDON ... Infosys Finacle, part of EdgeVerve Systems, a ... ), and Onegini today announced a partnership to ... banking solutions.      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ... banks to provide their customers enhanced security to ...
(Date:4/15/2016)... April 15, 2016 Research ... Gait Biometrics Market 2016-2020,"  report to their offering.  ... ) , ,The global gait biometrics market is ... during the period 2016-2020. Gait analysis ... can be used to compute factors that are ...
Breaking Biology News(10 mins):